课题基金 / 基金详情

PPAR-gamma agonists as novel interventions for severe malaria

PPAR-gamma agonists as novel interventions for severe malaria
PPAR-γ 激动剂作为治疗严重疟疾的新型干预措施
批准号:
303745
负责人:
Kain Kevin C
金额:
$44.28万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-03-01 至 2018-03-01

项目摘要

项目成果

Kain Kevin C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malaria is the most important parasitic disease in the world causing an estimated 225 million infections and 1.24 million deaths annually. Even with optimal anti-malaria treatment, severe or cerebral malaria is associated with a 10-30% mortality rate and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Randomized trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among COVID-19 patients in Mumbai, India
  • 批准号:
    429404
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.62万
  • 财政年份:
    2020
  • 负责人:
    Kain Kevin C
  • 依托单位:
Canada Research Chair Tier 1
  • 批准号:
    335763
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2015
  • 负责人:
    Kain Kevin C
  • 依托单位:
New biomarkers and interventions for life-threatening infections: malaria as a model
  • 批准号:
    333510
  • 项目类别:
    Operating Grants
  • 资助金额:
    $248.77万
  • 财政年份:
    2015
  • 负责人:
    Kain Kevin C
  • 依托单位:
Malaria and HIV Disease Interactions In Pregnancy
  • 批准号:
    252541
  • 项目类别:
    Operating Grants
  • 资助金额:
    $53.43万
  • 财政年份:
    2012
  • 负责人:
    Kain Kevin C
  • 依托单位:
海外基金